

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.30689245 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.30689245 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.30689245 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.30689245 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.30689245 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.30689245 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.56997838 |
| 8 | detection of molecule of bacterial origin (GO:0032490) | 5.55730766 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 5.50374982 |
| 10 | negative regulation of cell killing (GO:0031342) | 5.44819272 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.44819272 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.22674577 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 5.16826565 |
| 14 | microglial cell activation (GO:0001774) | 5.16553226 |
| 15 | response to peptidoglycan (GO:0032494) | 5.05290828 |
| 16 | negative regulation of interleukin-12 production (GO:0032695) | 4.97045550 |
| 17 | detection of other organism (GO:0098543) | 4.95819594 |
| 18 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.82554447 |
| 19 | detection of external biotic stimulus (GO:0098581) | 4.78677818 |
| 20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.69444857 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.53774823 |
| 22 | immunoglobulin mediated immune response (GO:0016064) | 4.52979184 |
| 23 | detection of bacterium (GO:0016045) | 4.50391716 |
| 24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.47308529 |
| 25 | macrophage activation (GO:0042116) | 4.34441244 |
| 26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.31450344 |
| 27 | response to host immune response (GO:0052572) | 4.29452345 |
| 28 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.29452345 |
| 29 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.28810245 |
| 30 | cellular extravasation (GO:0045123) | 4.23904482 |
| 31 | detection of biotic stimulus (GO:0009595) | 4.23416931 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 4.05122618 |
| 33 | leukocyte aggregation (GO:0070486) | 3.94723964 |
| 34 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.94541526 |
| 35 | neutrophil activation (GO:0042119) | 3.89383202 |
| 36 | response to host (GO:0075136) | 3.89019592 |
| 37 | response to host defenses (GO:0052200) | 3.89019592 |
| 38 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.89019592 |
| 39 | myeloid cell activation involved in immune response (GO:0002275) | 3.86317689 |
| 40 | respiratory burst (GO:0045730) | 3.85622409 |
| 41 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.84673403 |
| 42 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.84410473 |
| 43 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.83952664 |
| 44 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.79673473 |
| 45 | myeloid leukocyte mediated immunity (GO:0002444) | 3.78086444 |
| 46 | granulocyte activation (GO:0036230) | 3.74450372 |
| 47 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.69086186 |
| 48 | cellular response to type I interferon (GO:0071357) | 3.66773996 |
| 49 | type I interferon signaling pathway (GO:0060337) | 3.66773996 |
| 50 | response to type I interferon (GO:0034340) | 3.64493584 |
| 51 | regulation of mast cell degranulation (GO:0043304) | 3.61757567 |
| 52 | B cell mediated immunity (GO:0019724) | 3.55028250 |
| 53 | neutrophil mediated immunity (GO:0002446) | 3.53396981 |
| 54 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.47692266 |
| 55 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.46470994 |
| 56 | positive regulation of interferon-alpha production (GO:0032727) | 3.46240041 |
| 57 | regulation of hypersensitivity (GO:0002883) | 3.45606947 |
| 58 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.45528272 |
| 59 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.43879143 |
| 60 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.39190112 |
| 61 | positive regulation of mast cell activation (GO:0033005) | 3.39035933 |
| 62 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.35478557 |
| 63 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.31341530 |
| 64 | regulation of interferon-alpha production (GO:0032647) | 3.30887832 |
| 65 | germinal center formation (GO:0002467) | 3.29422244 |
| 66 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.28535526 |
| 67 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.27917047 |
| 68 | regulation of mast cell activation (GO:0033003) | 3.27335036 |
| 69 | response to muramyl dipeptide (GO:0032495) | 3.26893968 |
| 70 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.26061654 |
| 71 | negative regulation of T cell mediated immunity (GO:0002710) | 3.23272780 |
| 72 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.21360936 |
| 73 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.18546238 |
| 74 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.18412414 |
| 75 | positive regulation of mast cell degranulation (GO:0043306) | 3.16638072 |
| 76 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.16638072 |
| 77 | regulation of leukocyte degranulation (GO:0043300) | 3.15216517 |
| 78 | defense response to protozoan (GO:0042832) | 3.14572883 |
| 79 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.13552436 |
| 80 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.07273156 |
| 81 | regulation of tolerance induction (GO:0002643) | 3.06849014 |
| 82 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.06681849 |
| 83 | B cell receptor signaling pathway (GO:0050853) | 2.99997757 |
| 84 | T-helper 1 type immune response (GO:0042088) | 2.99786149 |
| 85 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.99058583 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.99058583 |
| 87 | myeloid leukocyte activation (GO:0002274) | 2.98857796 |
| 88 | response to interleukin-15 (GO:0070672) | 2.98344411 |
| 89 | regulation of T cell tolerance induction (GO:0002664) | 2.98050454 |
| 90 | positive regulation of antigen processing and presentation (GO:0002579) | 2.94431259 |
| 91 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93938632 |
| 92 | positive regulation of interferon-beta production (GO:0032728) | 2.91263451 |
| 93 | neutrophil chemotaxis (GO:0030593) | 2.87443189 |
| 94 | negative regulation of innate immune response (GO:0045824) | 2.86905753 |
| 95 | regulation of antigen processing and presentation (GO:0002577) | 2.86152614 |
| 96 | leukocyte degranulation (GO:0043299) | 2.84485040 |
| 97 | positive regulation of type 2 immune response (GO:0002830) | 2.82623665 |
| 98 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.80605399 |
| 99 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.80449390 |
| 100 | neutrophil migration (GO:1990266) | 2.79878581 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.39091258 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.01432431 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.41967970 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.79355359 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.76569726 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.65452709 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.60585009 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.54361494 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.50958146 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.27217016 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.05928947 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.02197282 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.86443280 |
| 14 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.67734790 |
| 15 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.65764178 |
| 16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.58866995 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.52736579 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.52001012 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.49888810 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.44478189 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.40306598 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.34274522 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.28865037 |
| 24 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.25664026 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17014658 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 2.14871854 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.14656827 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.13548984 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.04489650 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.04151070 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.99348602 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.97442765 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.96349219 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.81822114 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.77989567 |
| 36 | * MYB_26560356_Chip-Seq_TH1_Human | 1.76481066 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.73744535 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67695351 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65256270 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.61540588 |
| 41 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.61368180 |
| 42 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.56388444 |
| 43 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53114887 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51321320 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48744556 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.48246448 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.47230984 |
| 48 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45289968 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41823814 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39918507 |
| 51 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38187323 |
| 52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.35914941 |
| 53 | GATA3_26560356_Chip-Seq_TH2_Human | 1.34845105 |
| 54 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32445918 |
| 55 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29506443 |
| 56 | MAF_26560356_Chip-Seq_TH2_Human | 1.28773417 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28216234 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26232534 |
| 59 | MYC_22102868_ChIP-Seq_BL_Human | 1.25839765 |
| 60 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24395255 |
| 61 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23668396 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22756887 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21592469 |
| 64 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21513532 |
| 65 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19755486 |
| 66 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15755919 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14330460 |
| 68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13415788 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11654849 |
| 70 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11483635 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10691300 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10449302 |
| 73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.10322311 |
| 74 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09976830 |
| 75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09886882 |
| 76 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09336769 |
| 77 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08014687 |
| 78 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06652041 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06571268 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00395280 |
| 81 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97139450 |
| 82 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95406786 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.92578917 |
| 84 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.86667619 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.85812502 |
| 86 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.85700316 |
| 87 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.84373500 |
| 88 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.81996761 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81145627 |
| 90 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80986539 |
| 91 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.78247443 |
| 92 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78186008 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74211668 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.72762715 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.72496338 |
| 96 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72318634 |
| 97 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72295922 |
| 98 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.71758313 |
| 99 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.70550203 |
| 100 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.70471704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.10866339 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.95830532 |
| 3 | MP0003303_peritoneal_inflammation | 3.69549882 |
| 4 | MP0003436_decreased_susceptibility_to | 3.67276237 |
| 5 | MP0002419_abnormal_innate_immunity | 3.17615249 |
| 6 | MP0009785_altered_susceptibility_to | 3.15596612 |
| 7 | MP0006082_CNS_inflammation | 3.06463511 |
| 8 | MP0005025_abnormal_response_to | 2.88947584 |
| 9 | MP0000685_abnormal_immune_system | 2.84828513 |
| 10 | MP0005671_abnormal_response_to | 2.82785195 |
| 11 | MP0001790_abnormal_immune_system | 2.76549545 |
| 12 | MP0005387_immune_system_phenotype | 2.76549545 |
| 13 | MP0001800_abnormal_humoral_immune | 2.74871791 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.70891377 |
| 15 | MP0008260_abnormal_autophagy | 2.62184999 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.52851566 |
| 17 | MP0002723_abnormal_immune_serum | 2.51979090 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.49177596 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.31871138 |
| 20 | MP0001819_abnormal_immune_cell | 2.30406043 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.29961328 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.29306681 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.23387495 |
| 24 | MP0001533_abnormal_skeleton_physiology | 2.08396631 |
| 25 | MP0000569_abnormal_digit_pigmentation | 2.03906608 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.96824035 |
| 27 | MP0002405_respiratory_system_inflammati | 1.91749937 |
| 28 | MP0009278_abnormal_bone_marrow | 1.89735389 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.80142365 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.79141809 |
| 31 | MP0009764_decreased_sensitivity_to | 1.74728768 |
| 32 | MP0000716_abnormal_immune_system | 1.70860715 |
| 33 | MP0003828_pulmonary_edema | 1.66571563 |
| 34 | MP0005310_abnormal_salivary_gland | 1.65955162 |
| 35 | MP0004883_abnormal_blood_vessel | 1.64572299 |
| 36 | MP0002398_abnormal_bone_marrow | 1.62953602 |
| 37 | MP0004947_skin_inflammation | 1.59324201 |
| 38 | MP0003690_abnormal_glial_cell | 1.55852886 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.53290546 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.52656656 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.52656656 |
| 42 | MP0008469_abnormal_protein_level | 1.50202643 |
| 43 | MP0003075_altered_response_to | 1.49470209 |
| 44 | MP0005451_abnormal_body_composition | 1.48020048 |
| 45 | MP0003763_abnormal_thymus_physiology | 1.45380527 |
| 46 | MP0002166_altered_tumor_susceptibility | 1.42148574 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.39142758 |
| 48 | MP0004510_myositis | 1.38705909 |
| 49 | MP0002998_abnormal_bone_remodeling | 1.35664121 |
| 50 | MP0002277_abnormal_respiratory_mucosa | 1.35303680 |
| 51 | MP0004381_abnormal_hair_follicle | 1.34208585 |
| 52 | MP0002722_abnormal_immune_system | 1.33932655 |
| 53 | MP0000604_amyloidosis | 1.33154342 |
| 54 | MP0000858_altered_metastatic_potential | 1.32583846 |
| 55 | MP0002429_abnormal_blood_cell | 1.31659504 |
| 56 | MP0000343_altered_response_to | 1.31075278 |
| 57 | MP0005164_abnormal_response_to | 1.30614699 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.29909003 |
| 59 | MP0002132_abnormal_respiratory_system | 1.27732484 |
| 60 | MP0003866_abnormal_defecation | 1.27095348 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.22698172 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.19452628 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.16574619 |
| 64 | MP0001853_heart_inflammation | 1.14524015 |
| 65 | MP0001851_eye_inflammation | 1.10667670 |
| 66 | MP0009840_abnormal_foam_cell | 1.10003306 |
| 67 | MP0002396_abnormal_hematopoietic_system | 1.08119665 |
| 68 | MP0005166_decreased_susceptibility_to | 1.03796154 |
| 69 | MP0000703_abnormal_thymus_morphology | 1.02931810 |
| 70 | MP0003448_altered_tumor_morphology | 1.02189846 |
| 71 | MP0000015_abnormal_ear_pigmentation | 0.97177253 |
| 72 | MP0002006_tumorigenesis | 0.95137643 |
| 73 | MP0005167_abnormal_blood-brain_barrier | 0.91319097 |
| 74 | MP0009763_increased_sensitivity_to | 0.89712487 |
| 75 | MP0003806_abnormal_nucleotide_metabolis | 0.88073809 |
| 76 | MP0005075_abnormal_melanosome_morpholog | 0.84513521 |
| 77 | MP0003221_abnormal_cardiomyocyte_apopto | 0.83942894 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 0.82177037 |
| 79 | MP0002332_abnormal_exercise_endurance | 0.80374140 |
| 80 | MP0003195_calcinosis | 0.77952621 |
| 81 | MP0008004_abnormal_stomach_pH | 0.76728218 |
| 82 | MP0005390_skeleton_phenotype | 0.75175137 |
| 83 | MP0003329_amyloid_beta_deposits | 0.71877381 |
| 84 | MP0000249_abnormal_blood_vessel | 0.71052376 |
| 85 | MP0001663_abnormal_digestive_system | 0.70959950 |
| 86 | MP0003787_abnormal_imprinting | 0.69434309 |
| 87 | MP0005174_abnormal_tail_pigmentation | 0.67777202 |
| 88 | MP0008874_decreased_physiological_sensi | 0.67330213 |
| 89 | MP0003045_fibrosis | 0.65829841 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.64281750 |
| 91 | MP0002138_abnormal_hepatobiliary_system | 0.64188440 |
| 92 | MP0003795_abnormal_bone_structure | 0.63515999 |
| 93 | MP0000920_abnormal_myelination | 0.61927303 |
| 94 | MP0003091_abnormal_cell_migration | 0.60428348 |
| 95 | MP0004484_altered_response_of | 0.59932529 |
| 96 | MP0004130_abnormal_muscle_cell | 0.58529605 |
| 97 | MP0002933_joint_inflammation | 0.57778478 |
| 98 | MP0006054_spinal_hemorrhage | 0.55889611 |
| 99 | MP0000371_diluted_coat_color | 0.54818543 |
| 100 | MP0005376_homeostasis/metabolism_phenot | 0.53112130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 6.49198876 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.40741450 |
| 3 | Recurrent abscess formation (HP:0002722) | 6.28164223 |
| 4 | Myositis (HP:0100614) | 5.56238924 |
| 5 | Orchitis (HP:0100796) | 5.50797541 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.40978292 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 5.37546977 |
| 8 | Optic neuritis (HP:0100653) | 5.37546977 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.01677979 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.65208129 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 4.38220567 |
| 12 | Stomatitis (HP:0010280) | 4.32476423 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 4.20677461 |
| 14 | Recurrent skin infections (HP:0001581) | 4.18579699 |
| 15 | Recurrent fungal infections (HP:0002841) | 4.09028166 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 3.81726225 |
| 17 | Obstructive lung disease (HP:0006536) | 3.81726225 |
| 18 | Keratoconjunctivitis sicca (HP:0001097) | 3.81220627 |
| 19 | Gingivitis (HP:0000230) | 3.79428135 |
| 20 | Meningitis (HP:0001287) | 3.75286974 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.66899370 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.66899370 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.66532514 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.57602305 |
| 25 | Keratoconjunctivitis (HP:0001096) | 3.51318933 |
| 26 | Encephalitis (HP:0002383) | 3.43324568 |
| 27 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.33784784 |
| 28 | Hemoptysis (HP:0002105) | 3.26418343 |
| 29 | Vasculitis (HP:0002633) | 3.25402775 |
| 30 | Urticaria (HP:0001025) | 3.24385724 |
| 31 | Peritonitis (HP:0002586) | 3.18158790 |
| 32 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.12463993 |
| 33 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.12463993 |
| 34 | Abnormality of glycolipid metabolism (HP:0010969) | 3.12463993 |
| 35 | Amyloidosis (HP:0011034) | 3.11431725 |
| 36 | Chest pain (HP:0100749) | 3.09338628 |
| 37 | T lymphocytopenia (HP:0005403) | 3.08494609 |
| 38 | Arterial thrombosis (HP:0004420) | 3.08210446 |
| 39 | Systemic lupus erythematosus (HP:0002725) | 3.06390621 |
| 40 | Pulmonary infiltrates (HP:0002113) | 3.05636115 |
| 41 | Abnormality of T cell number (HP:0011839) | 3.03333973 |
| 42 | Gingival bleeding (HP:0000225) | 2.93905842 |
| 43 | Increased cerebral lipofuscin (HP:0011813) | 2.91532389 |
| 44 | Cellulitis (HP:0100658) | 2.85596073 |
| 45 | Leukocytosis (HP:0001974) | 2.81026571 |
| 46 | Increased IgE level (HP:0003212) | 2.79200790 |
| 47 | Episodic fever (HP:0001954) | 2.77671294 |
| 48 | Recurrent viral infections (HP:0004429) | 2.72979543 |
| 49 | Anorexia (HP:0002039) | 2.67702416 |
| 50 | Pulmonary embolism (HP:0002204) | 2.65909531 |
| 51 | Hypochromic microcytic anemia (HP:0004840) | 2.63359318 |
| 52 | Osteomyelitis (HP:0002754) | 2.62578101 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.57418192 |
| 54 | Epistaxis (HP:0000421) | 2.55638465 |
| 55 | Abnormality of the peritoneum (HP:0002585) | 2.52526085 |
| 56 | Chronic otitis media (HP:0000389) | 2.50217477 |
| 57 | Hypochromic anemia (HP:0001931) | 2.48639131 |
| 58 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.45773023 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.44050547 |
| 60 | Disinhibition (HP:0000734) | 2.43487568 |
| 61 | Gangrene (HP:0100758) | 2.41191631 |
| 62 | Abnormality of T cells (HP:0002843) | 2.38490039 |
| 63 | Inflammation of the large intestine (HP:0002037) | 2.37878324 |
| 64 | Loss of speech (HP:0002371) | 2.35996986 |
| 65 | Abnormality of the pleura (HP:0002103) | 2.35178787 |
| 66 | Gastrointestinal inflammation (HP:0004386) | 2.22959442 |
| 67 | Vertigo (HP:0002321) | 2.21986562 |
| 68 | Abnormality of the endocardium (HP:0004306) | 2.21199901 |
| 69 | Increased IgM level (HP:0003496) | 2.21168298 |
| 70 | Slow saccadic eye movements (HP:0000514) | 2.15605911 |
| 71 | Granulocytopenia (HP:0001913) | 2.15224176 |
| 72 | Sepsis (HP:0100806) | 2.10754674 |
| 73 | Pustule (HP:0200039) | 2.10310435 |
| 74 | Glomerulonephritis (HP:0000099) | 2.08595491 |
| 75 | Hypergammaglobulinemia (HP:0010702) | 2.08350702 |
| 76 | Microcytic anemia (HP:0001935) | 2.08179170 |
| 77 | Increased serum ferritin (HP:0003281) | 2.06200194 |
| 78 | Glomerulopathy (HP:0100820) | 2.05745254 |
| 79 | Eosinophilia (HP:0001880) | 2.03305704 |
| 80 | Petechiae (HP:0000967) | 2.03241286 |
| 81 | Colitis (HP:0002583) | 2.01729903 |
| 82 | Cheilitis (HP:0100825) | 2.00813496 |
| 83 | Recurrent bronchitis (HP:0002837) | 2.00340114 |
| 84 | Panhypogammaglobulinemia (HP:0003139) | 2.00130720 |
| 85 | Premature loss of primary teeth (HP:0006323) | 1.96251849 |
| 86 | Polyneuropathy (HP:0001271) | 1.96135914 |
| 87 | Purpura (HP:0000979) | 1.94298529 |
| 88 | Abnormality of iron homeostasis (HP:0011031) | 1.94220231 |
| 89 | Abnormality of T cell physiology (HP:0011840) | 1.93747966 |
| 90 | Dysostosis multiplex (HP:0000943) | 1.92947704 |
| 91 | Keratitis (HP:0000491) | 1.90701349 |
| 92 | Abnormality of the pericardium (HP:0001697) | 1.90183946 |
| 93 | Skin ulcer (HP:0200042) | 1.89981903 |
| 94 | Recurrent pneumonia (HP:0006532) | 1.89418532 |
| 95 | Acne (HP:0001061) | 1.86487008 |
| 96 | Mutism (HP:0002300) | 1.86159637 |
| 97 | Acute hepatic failure (HP:0006554) | 1.84311159 |
| 98 | Thrombophlebitis (HP:0004418) | 1.84180212 |
| 99 | Postural instability (HP:0002172) | 1.82405938 |
| 100 | Vacuolated lymphocytes (HP:0001922) | 1.81883481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.77255149 |
| 2 | BLK | 3.92987893 |
| 3 | IRAK4 | 3.14925632 |
| 4 | TYK2 | 3.09118389 |
| 5 | MAP2K3 | 2.86754422 |
| 6 | MAP4K1 | 2.86682545 |
| 7 | CSK | 2.77175345 |
| 8 | FGR | 2.33678744 |
| 9 | FES | 2.30200176 |
| 10 | JAK3 | 2.23193787 |
| 11 | ERN1 | 2.10238023 |
| 12 | IKBKE | 2.03196045 |
| 13 | ZAP70 | 2.02646533 |
| 14 | MAP3K14 | 2.02142129 |
| 15 | TNK2 | 1.98963877 |
| 16 | TXK | 1.98438736 |
| 17 | GRK6 | 1.92619955 |
| 18 | SYK | 1.72380088 |
| 19 | BTK | 1.70469244 |
| 20 | EPHB1 | 1.68595768 |
| 21 | JAK1 | 1.61918214 |
| 22 | HCK | 1.60617109 |
| 23 | JAK2 | 1.58115297 |
| 24 | TAOK1 | 1.56224296 |
| 25 | TBK1 | 1.55809298 |
| 26 | LYN | 1.47090597 |
| 27 | MATK | 1.46480514 |
| 28 | MAP3K13 | 1.46478673 |
| 29 | MAP3K3 | 1.43751188 |
| 30 | MAP3K11 | 1.37188745 |
| 31 | IRAK1 | 1.36206364 |
| 32 | CSF1R | 1.35666619 |
| 33 | KIT | 1.31861069 |
| 34 | TGFBR2 | 1.31251270 |
| 35 | TAOK3 | 1.28401257 |
| 36 | PRPF4B | 1.22834807 |
| 37 | IRAK2 | 1.22000595 |
| 38 | MAP3K1 | 1.19675238 |
| 39 | MAP3K6 | 1.15497985 |
| 40 | BMPR2 | 1.13915157 |
| 41 | IKBKB | 1.13399979 |
| 42 | YES1 | 1.12335509 |
| 43 | LCK | 1.11432265 |
| 44 | GRK7 | 1.07699785 |
| 45 | MARK3 | 1.03229787 |
| 46 | KSR2 | 1.00479151 |
| 47 | ITK | 0.98689728 |
| 48 | TEC | 0.98470919 |
| 49 | MARK2 | 0.95107009 |
| 50 | CAMK1D | 0.91847375 |
| 51 | PDK1 | 0.84230389 |
| 52 | MAP3K5 | 0.83934971 |
| 53 | FGFR3 | 0.83915627 |
| 54 | PTK2B | 0.79804894 |
| 55 | SIK3 | 0.79326373 |
| 56 | MAP3K2 | 0.78954960 |
| 57 | PIK3CG | 0.78534185 |
| 58 | CDC42BPA | 0.74820575 |
| 59 | PDPK1 | 0.72977167 |
| 60 | FGFR4 | 0.72579965 |
| 61 | TAOK2 | 0.72478119 |
| 62 | CAMKK2 | 0.71386326 |
| 63 | STK10 | 0.71227004 |
| 64 | LRRK2 | 0.68843649 |
| 65 | IRAK3 | 0.68821715 |
| 66 | SIK2 | 0.65006369 |
| 67 | EPHA3 | 0.64863573 |
| 68 | MAP2K4 | 0.62279706 |
| 69 | FYN | 0.61683036 |
| 70 | PTK6 | 0.61146348 |
| 71 | SGK3 | 0.58581950 |
| 72 | PIM1 | 0.57041946 |
| 73 | MAP2K6 | 0.54094575 |
| 74 | PRKD2 | 0.52839596 |
| 75 | SGK2 | 0.51398450 |
| 76 | KSR1 | 0.51152829 |
| 77 | ACVR1B | 0.50903529 |
| 78 | STK11 | 0.49346157 |
| 79 | CHUK | 0.47448193 |
| 80 | HIPK2 | 0.46891293 |
| 81 | RET | 0.46161019 |
| 82 | CAMK1G | 0.44955648 |
| 83 | MAPK7 | 0.44232602 |
| 84 | MAPK12 | 0.43990002 |
| 85 | WNK1 | 0.43014687 |
| 86 | CDK19 | 0.41243437 |
| 87 | RPS6KL1 | 0.40195576 |
| 88 | RPS6KC1 | 0.40195576 |
| 89 | MAP3K7 | 0.40135579 |
| 90 | MAPKAPK2 | 0.39625444 |
| 91 | FRK | 0.38841164 |
| 92 | DYRK1B | 0.38422763 |
| 93 | DAPK2 | 0.38153687 |
| 94 | CAMK4 | 0.37616486 |
| 95 | CDK6 | 0.37262675 |
| 96 | MOS | 0.36933211 |
| 97 | RPS6KA6 | 0.36444882 |
| 98 | DYRK3 | 0.34081170 |
| 99 | TRIB3 | 0.33387823 |
| 100 | GRK5 | 0.33007738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.44721665 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.30468356 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.12534362 |
| 4 | Tuberculosis_Homo sapiens_hsa05152 | 2.39385385 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.39027204 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.30476256 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.28868930 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.18617423 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.09310490 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.08817085 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.05017449 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.97657321 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.95797729 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 1.89435474 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.88119775 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.77158615 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.72095827 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.71076923 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.70339969 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.69886173 |
| 21 | Phagosome_Homo sapiens_hsa04145 | 1.66329993 |
| 22 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.62403319 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.61958633 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.58300624 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.55461778 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.54743693 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.52064611 |
| 28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.50882548 |
| 29 | Asthma_Homo sapiens_hsa05310 | 1.48489523 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.46263367 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.44125679 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.43280769 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.40431935 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.35614967 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32830132 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31191252 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.31091265 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.30978055 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28620823 |
| 40 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.27070472 |
| 41 | Lysosome_Homo sapiens_hsa04142 | 1.25429293 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.23155598 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.08321941 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 1.07856740 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.07763321 |
| 46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.04570099 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.03327216 |
| 48 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99010329 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97999181 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94510368 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92029392 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89412847 |
| 53 | Apoptosis_Homo sapiens_hsa04210 | 0.88244452 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 0.85164539 |
| 55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82960316 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82704692 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76521718 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74424329 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74253402 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71685499 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70311562 |
| 62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68173719 |
| 63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67121489 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66616716 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66335357 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64990728 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64426707 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63812554 |
| 69 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63482153 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62443109 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61842842 |
| 72 | Amoebiasis_Homo sapiens_hsa05146 | 0.60256258 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58929989 |
| 74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58865471 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.58775940 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58267334 |
| 77 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.57582770 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54682578 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54350837 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54124622 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.53970417 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52875713 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51645477 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50254825 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49885173 |
| 86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47408687 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40821640 |
| 88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40145334 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39947577 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39748086 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38391384 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38048632 |
| 93 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36665055 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35467325 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34920686 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.33749847 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.33359503 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33052796 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32886286 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31720574 |

